SpaceX's Reality Check: 319 Million Shares Unlock as Stock Sinks Below IPO

SpaceX trades below its $135 June IPO price today, which would be an amusing detail if not for Tuesday's calendar event: approximately 319 million insider shares become eligible for sale on September 9, marking the third unlock in what has become the market's most theatrical lockup schedule.

The company raised $75 billion on June 12 at that $135 anchor price, then surged over 67 percent to above $225 in the weeks that followed. Retail accounts, hedge funds, and thematic ETFs poured capital into a float so small it barely qualified as one—roughly 4 to 5 percent of total shares outstanding. Supply-demand math being what it always is, the stock climbed. Now the supply side of that equation gets a rewrite.

The August 6 unlock provided a preview. That event released 20 percent of the 180-day block, potentially freeing up to 911.5 million shares after Q2 earnings. The company also had a performance-based bonus tranche of 455.8 million shares on the books, but those did not release because SpaceX was not trading 30 percent above the $135 IPO price—a threshold that, given current prices, now looks prophetic. Those locked shares rolled forward to the December 8 expiration, making that cliff substantially steeper than originally modeled. Someone in financial planning saw this coming.

Tuesday's 319-million-share unlock follows a fixed prospectus schedule the company filed at IPO. The remaining tranches expire August 20, September 9, September 24, October 9, October 24, and December 8, 2026. By October 31, publicly available shares are estimated to comprise roughly one-third of the entire company. The float will expand sixfold as successive 7-percent employee tranches hit their expirations throughout September and October. That is not a gradual transition. That is a structural cliff.

What happens next is not predetermined, though history offers some guidance. Early investors—the ones who hold shares from pre-IPO allocations and employee option grants—face a choice that clarifies as the lockup calendar ticks forward. Sell into what remains of the rally and lock in returns, or hold and watch your theoretical gains compress as the supply picture deteriorates. The stock trading below IPO price makes that calculation considerably simpler for most participants. This was not supposed to be the scenario.

Elon Musk and select major holders remain under a separate ~366-day lockup running until approximately June 13, 2027. They are not selling Tuesday. The employees and earlier investors who are eligible to sell on September 9 operate under different constraints. They have no reason to hold if they believe the float expansion will continue pressuring the price downward, and they have every reason to sell if they believe current levels represent a reasonable exit relative to risk.

The mathematical reality is straightforward: a tiny float plus massive unlock equals downward pressure unless buying volume swells dramatically. The buyer base that drove the stock from $135 to $225 was working with scarcity as the primary feature. That scarcity is about to end. Whether new flows arrive to absorb 319 million shares on Tuesday, and then another round in September and October, will determine whether the initial investors made a genius allocation or simply paid a premium price for an illiquid asset in a crowded trade. The spreadsheet reveals the answer on September 9.